Optimer Pharmaceuticals (OPTR) Tops Q2 EPS by 7c
Tweet Send to a Friend
Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q2 EPS of ($0.55), $0.07 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
